Sequential Duo-Peptide receptor radionuclide therapy with indigenous 90Y-DOTATATE and 177Lu-DOTATATE in large-volume neuroendocrine tumors: Posttherapy Bremsstrahlung and PET/CT imaging following 90Y-DOTATATE treatment

dc.contributor.authorParghane, R. V.
dc.contributor.authorMitra, A.
dc.contributor.authorUpadhye, T.
dc.contributor.authorRakshit, S.
dc.contributor.authorBanerjee, S.
dc.contributor.authorBasu, Sandip
dc.date.accessioned2021-01-13T06:15:04Z
dc.date.available2021-01-13T06:15:04Z
dc.date.issued2020
dc.description.divisionRMCen
dc.format.extent4310 bytes
dc.format.mimetypetext/html
dc.identifier.sourceClinical Nuclear Medicine, 2020.: pp. 714-715: Article no. 45en
dc.identifier.urihttp://hdl.handle.net/123456789/21847
dc.language.isoenen
dc.subject177Luen
dc.subject90Yen
dc.subjectneuroendocrine tumoren
dc.subjectpeptide receptors radionuclide therapyen
dc.subjectsequential duo-PRRTen
dc.titleSequential Duo-Peptide receptor radionuclide therapy with indigenous 90Y-DOTATATE and 177Lu-DOTATATE in large-volume neuroendocrine tumors: Posttherapy Bremsstrahlung and PET/CT imaging following 90Y-DOTATATE treatmenten
dc.typeArticleen

Click here to download

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
0191.htm
Size:
4.21 KB
Format:
Hypertext Markup Language
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.81 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections